Victory Capital Management’s Atara Biotherapeutics ATRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-422	Closed	-$15.6K	–	2542
2023 Q3	$15.6K	Buy	422 +19	+5%	+$846	﹤0.01%	2462
2023 Q2	$16.2K	Sell	403 -10	-2%	-$565	﹤0.01%	2459
2023 Q1	$29.9K	Buy	413 +2	+0.5%	+$194	﹤0.01%	2483
2022 Q4	$33.7K	Hold	411	–	–	﹤0.01%	2483
2022 Q3	$39K	Sell	411 -46	-10%	-$5.17K	﹤0.01%	2582
2022 Q2	$89K	Buy	457 +17	+4%	+$2.77K	﹤0.01%	2471
2022 Q1	$70K	Sell	440 -13	-3%	-$4.14K	﹤0.01%	2562
2021 Q4	$178K	Buy	453 +11	+2%	+$4.63K	﹤0.01%	2504
2021 Q3	$198K	Sell	442 -51	-10%	-$18.3K	﹤0.01%	2528
2021 Q2	$192K	Sell	493 -12	-2%	-$4.28K	﹤0.01%	2532
2021 Q1	$181K	Sell	505 -19	-4%	-$8.4K	﹤0.01%	2536
2020 Q4	$257K	Buy	524 +80	+18%	+$36.9K	﹤0.01%	2326
2020 Q3	$144K	Sell	444 -9	-2%	-$3.06K	﹤0.01%	2320
2020 Q2	$165K	Sell	453 -301	-40%	-$76K	﹤0.01%	2322
2020 Q1	$160K	Buy	754 +339	+82%	+$108K	﹤0.01%	2389
2019 Q4	$171K	Buy	415 +99	+31%	+$34.1K	﹤0.01%	2349
2019 Q3	$112K	Buy	+316	New	+$118K	﹤0.01%	2399